BioPharmGuy logo
Sponsored By:
Trianni Inc.
BioPharmGuy Database
Emery Pharma
Genelabs Technologies is defunct.

Fate: Acquired by GSK, Oct 2008, $57M


------------------
If you believe any of this information is incorrect, please let us know.